Kolkata headquartered Medica Hospitals has launched the ‘Medica Centre for Liver Disease’ in association with the renowned South Asian Liver Institute (SALi), a Tom Cherian initiative.
Medica Centre for Liver Disease aims to meet a growing requirement for treatment of liver conditions, including transplant, in Eastern India. The Centre is equipped to handle most diseases of liver, pancreas and gall bladder. Medica’s liver transplant program will involve both living and cadaver donors. Medica is amongst a very few hospitals in the region with comprehensive facilities for treatment of complex liver diseases transplant surgery.
This is a great addition to the existing liver disease management team at Medica, led by the experienced Gastroenterologist & Hepatologist Dr Pradeepta Kumar Sethy, Director of Gastroenterology, Medica Superspecialty Hospital. “It is indeed a timely decision to come up with the Centre for Liver Diseases. No doubt, we can have a focussed holistic approach in dealing with patients suffering from such ailments and diseases,” said Dr Sethy.
Talking about The Medica Centre for Liver Disease, Prof (Dr.) Tom Cherian, Founder, South Asian Liver Institute (SALi) said “We want to try and make the treatment of liver disease, WORLD CLASS. And what is world class? It simply means there must be no difference in the treatment of a patient with liver disease between Kolkata & London. I promise to make every treatment that I used to perform in London for liver disease, eventually available here in Kolkata! We have already treated several patients from Kolkata, who are doing well and back in the city now, but had to travel far previously for their treatment. I am glad we are able to bring this treatment to this great city, which deserves a superb liver service.”
Dr. Alok Roy, Chairman, Medica Group of Hospitals said, “This Centre for Liver Diseases is a huge step, and I believe, this is a milestone not only in Kolkata and Bengal but also in Eastern India as a whole. We have a fantastic team of doctors, surgeons, and infrastructure to deal with liver diseases and associated complications.”